Repeated amphetamine treatment induces neurite outgrowth and enhanced amphetamine-stimulated dopamine release in rat pheochromocytoma cells (PC12 cells) via a protein kinase C- and mitogen activated protein kinase-dependent mechanism
dc.contributor.author | Park, Yang Hae | en_US |
dc.contributor.author | Kantor, Lana | en_US |
dc.contributor.author | Guptaroy, Bipasha | en_US |
dc.contributor.author | Zhang, Minjia | en_US |
dc.contributor.author | Wang, Kevin K. W. | en_US |
dc.contributor.author | Gnegy, Margaret E. | en_US |
dc.date.accessioned | 2010-04-01T15:33:20Z | |
dc.date.available | 2010-04-01T15:33:20Z | |
dc.date.issued | 2003-12 | en_US |
dc.identifier.citation | Park, Yang Hae; Kantor, Lana; Guptaroy, Bipasha; Zhang, Minjia; Wang, Kevin K. W.; Gnegy, Margaret E. (2003). "Repeated amphetamine treatment induces neurite outgrowth and enhanced amphetamine-stimulated dopamine release in rat pheochromocytoma cells (PC12 cells) via a protein kinase C- and mitogen activated protein kinase-dependent mechanism." Journal of Neurochemistry 87(6): 1546-1557. <http://hdl.handle.net/2027.42/66040> | en_US |
dc.identifier.issn | 0022-3042 | en_US |
dc.identifier.issn | 1471-4159 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/66040 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=14713310&dopt=citation | en_US |
dc.description.abstract | Repeated intermittent treatment with amphetamine (AMPH) induces both neurite outgrowth and enhanced AMPH-stimulated dopamine (DA) release in PC12 cells. We investigated the role of protein kinases in the induction of these AMPH-mediated events by using inhibitors of protein kinase C (PKC), mitogen activated protein kinase (MAP kinase) or protein kinase A (PKA). PKC inhibitors chelerythrine (100 nm and 300 nm), Ro31-8220 (300 nm) and the MAP kinase kinase inhibitor, PD98059 (30 µm) inhibited the ability of AMPH to elicit both neurite outgrowth and the enhanced AMPH-stimulated DA release. The direct-acting PKC activator, 12- O -tetradecanoyl phorbol 13-acetate (TPA, 250 nm) mimicked the ability of AMPH to elicit neurite outgrowth and enhanced DA release. On the contrary, a selective PKA inhibitor, 100 µm Rp-8-Br-cAMPS, blocked only the development of AMPH-stimulated DA release but not the neurite outgrowth. Treatment of the cells with acute AMPH elicited an increase in the activity of PKC and MAP kinase but not PKA. These results demonstrated that AMPH-induced increases in MAP kinase and PKC are important for induction of both the enhancement in transporter-mediated DA release and neurite outgrowth but PKA was only required for the enhancement in AMPH-stimulated DA release. Therefore the mechanisms by which AMPH induces neurite outgrowth and the enhancement in AMPH-stimulated DA release can be differentiated. | en_US |
dc.format.extent | 402790 bytes | |
dc.format.extent | 3110 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Science Ltd | en_US |
dc.rights | 2003 International Society for Neurochemistry | en_US |
dc.subject.other | Cultured Cells | en_US |
dc.subject.other | Extracellular Signal-regulated Kinase | en_US |
dc.subject.other | Neurite Outgrowth | en_US |
dc.subject.other | Protein Kinases | en_US |
dc.subject.other | Repeated Amphetamine | en_US |
dc.subject.other | Transporter-mediated Dopamine Release | en_US |
dc.title | Repeated amphetamine treatment induces neurite outgrowth and enhanced amphetamine-stimulated dopamine release in rat pheochromocytoma cells (PC12 cells) via a protein kinase C- and mitogen activated protein kinase-dependent mechanism | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Neurosciences | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | * Department of Pharmacology, University of Michigan School of Medicine, Ann Arbor, Michigan, USA | en_US |
dc.contributor.affiliationother | † Departments of Psychiatry & Neuroscience, University of Florida, Gainesville, Florida, USA | en_US |
dc.identifier.pmid | 14713310 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/66040/1/j.1471-4159.2003.02127.x.pdf | |
dc.identifier.doi | 10.1046/j.1471-4159.2003.02127.x | en_US |
dc.identifier.source | Journal of Neurochemistry | en_US |
dc.identifier.citedreference | Bauman A. L., Apparsundaram S., Ramamoorthy S., Wadzinski B. E., Vaughan R. A. and Blakely R. D. ( 2000 ) Cocaine and antidepressant-sensitive biogenic amine transporters exist in regulated complexes with protein phosphatase 2A. J. Neurosci. 20, 7571 – 7578. | en_US |
dc.identifier.citedreference | Ben-Shlomo H., Sigmund O., Stabel S., Reiss N. and Naor Z. ( 1991 ) Preferential release of catecholamine from permeabilized PC12 cells by alpha- and beta-type protein kinase C subspecies. Biochem. J. 280, 65 – 69. | en_US |
dc.identifier.citedreference | Berhow M. T., Hiroi N. and Nestler E. J. ( 1996 ) Regulation of ERK (extracellular signal regulated kinase), part of the neurotrophin signal transduction cascade, in the rat mesolimbic dopamine system by chronic exposure to morphine or cocaine. J. Neurosci. 16, 4707 – 4715. | en_US |
dc.identifier.citedreference | Blakely R. D., Ramamoorthy S., Schroeter S., Qian Y., Apparsundaram S., Galli A. and DeFelice L. J. ( 1998 ) Regulated phosphorylation and trafficking of antidepressant-sensitive serotonin transporter proteins. Biol. Psychiatry 44, 169 – 178. | en_US |
dc.identifier.citedreference | Bonisch H. ( 1984 ) The transport of (+)-amphetamine by the neuronal noradrenaline carrier. Naunyn Schmiedebergs Arch. Pharmacol. 327, 267 – 272. | en_US |
dc.identifier.citedreference | Borgatti P., Mazzoni M., Carini C., Neri L. M., Marchisio M., Bertolaso L., Previati M., Zauli G. and Capitani S. ( 1996 ) Changes of nuclear protein kinase C activity and isotype composition in PC12 cell proliferation and differentiation. Exp. Cell Res. 224, 72 – 78. | en_US |
dc.identifier.citedreference | Brandon E. P., Logue S. F., Adams M. R., Qi M., Sullivan S. P., Matsumoto A. M., Dorsa D. M., Wehner J. M., McKnight G. S. and Idzerda R. L. ( 1998 ) Defective motor behavior and neural gene expression in RIIbeta-protein kinase A mutant mice. J. Neurosci. 18, 3639 – 3649. | en_US |
dc.identifier.citedreference | Browman K. E., Kantor L., Richardson S., Badiani A., Robinson T. E. and Gnegy M. E. ( 1998 ) Injection of the protein kinase C inhibitor Ro31-8220 into the nucleus accumbens attenuates the acute response to amphetamine: tissue and behavioral studies. Brain Res. 814, 112 – 119. | en_US |
dc.identifier.citedreference | Bunzow J. R., Sonders M. S., Arttamangkul S. et al. ( 2001 ) Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. Mol. Pharmacol. 60, 1181 – 1188. | en_US |
dc.identifier.citedreference | Chen Y. H., Chow S. N. and Tsai M. C. ( 1998 ) Ratiometric confocal Ca 2+ measurements with visible wavelength indicators in d-amphetamine-treated central snail neuron. General Pharmacol. 31, 783 – 788. | en_US |
dc.identifier.citedreference | Choe E. S., Chung K. T., Mao L. and Wang J. Q. ( 2002 ) Amphetamine increases phosphorylation of extracellular signal-regulated kinase and transcription factors in the rat striatum via group I metabotropic glutamate receptors. Neuropsychopharmacology 27, 565 – 575. | en_US |
dc.identifier.citedreference | Cowell R. M., Kantor L., Hewlett G. H., Frey K. A. and Gnegy M. E. ( 2000 ) Dopamine transporter antagonists block phorbol ester-induced dopamine release and dopamine transporter phosphorylation in striatal synaptosomes. Eur. J. Pharmacol. 389, 59 – 65. | en_US |
dc.identifier.citedreference | Crisostomo E. A., Duncan P. W., Propst M., Dawson D. V. and Davis J. N. ( 1988 ) Evidence that amphetamine with physical therapy promotes recovery of motor function in stroke patients. Ann. Neurol. 23, 94 – 97. | en_US |
dc.identifier.citedreference | Daniels G. M. and Amara S. G. ( 1999 ) Regulated trafficking of the human dopamine transporter. Clathrin-mediated internalization and lysosomal degradation in response to phorbol esters. J. Biol. Chem. 274, 35794 – 35801. | en_US |
dc.identifier.citedreference | Davies S. P., Reddy H., Caivano M. and Cohen P. ( 2000 ) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351, 1 – 105. | en_US |
dc.identifier.citedreference | Derbez A. E., Mody R. M. and Werling L. L. ( 2002 ) Sigma (2)-receptor regulation of dopamine transporter via activation of protein kinase C. J. Pharmacol. Exp. Ther. 301, 306 – 314. | en_US |
dc.identifier.citedreference | Giambalvo C. T. ( 1992a ) Protein kinase C and dopamine transport – 1. Effects of amphetamine in vivo. Neuropharmacology 31, 1201 – 1210. | en_US |
dc.identifier.citedreference | Giambalvo C. T. ( 1992b ) Protein kinase C and dopamine transport – 2. Effects of amphetamine in vitro. Neuropharmacology 31, 1211 – 1222. | en_US |
dc.identifier.citedreference | Gjertsen B. T., Mellgren G., Otten A., Maronde E., Genieser H. G., Jastorff B., Vintermyr O. K., McKnight G. S. and Doskeland S. O. ( 1995 ) Novel (Rp)-cAMPS analogs as tools for inhibition of cAMP-kinase in cell culture. Basal cAMP-kinase activity modulates interleukin-1 beta action. J. Biol. Chem. 270, 20599 – 20607. | en_US |
dc.identifier.citedreference | Gnegy M. E., Hong P. and Ferrell S. T. ( 1993 ) Phosphorylation of neuromodulin in rat striatum after acute and repeated, intermittent amphetamine. Brain Res. Mol. Brain Res. 20, 289 – 298. | en_US |
dc.identifier.citedreference | Greene L. A. and Tischler A. S. ( 1976 ) Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl Acad. Sci. USA 73, 2424 – 2428. | en_US |
dc.identifier.citedreference | Hall F. L., Fernyhough P., Ishii D. N. and Vulliet P. R. ( 1988 ) Suppression of nerve growth factor-directed neurite outgrowth in PC12 cells by sphingosine, an inhibitor of protein kinase C. J. Biol. Chem. 263, 4460 – 4466. | en_US |
dc.identifier.citedreference | Hansen T. O., Rehfeld J. F. and Nielsen F. C. ( 2000 ) Cyclic AMP-induced neuronal differentiation via activation of p38 mitogen-activated protein kinase. J. Neurochem. 75, 1870 – 1877. | en_US |
dc.identifier.citedreference | Hug H. and Sarre T. F. ( 1993 ) Protein kinase C isoenzymes: Divergence in signal transduction. Biochem. J. 291, 329 – 343. | en_US |
dc.identifier.citedreference | Ingram S. L. and Amara S. G. ( 2000 ) Arachidonic acid stimulates a novel cocaine-sensitive cation conductance associated with the human dopamine transporter. J. Neurosci. 20, 550 – 557. | en_US |
dc.identifier.citedreference | Iwata S., Hewlett G. H. K., Ferrell S. T., Czernik A. J., Meiri K. F. and Gnegy M. E. ( 1996 ) Increased in vivo phosphorylation of neuromodulin and synapsin I in striatum from rats treated with repeated amphetamine. J. Pharmacol. Exp. Ther. 278, 1428 – 1434. | en_US |
dc.identifier.citedreference | Iwata S., Hewlett G. H. K., Ferrell S. T., Kantor L. and Gnegy M. E. ( 1997a ) Enhanced dopamine release and phosphorylation of synapsin I and neuromodulin in striatal synaptosomes after repeated amphetamine. J. Pharmacol. Exp. Ther. 283, 1445 – 1452. | en_US |
dc.identifier.citedreference | Iwata S., Hewlett G. H. K. and Gnegy M. E. ( 1997b ) Amphetamine increases the phosphorylation of neuromodulin and synapsin I in rat striatal synaptosomes. Synapse 26, 281 – 291. | en_US |
dc.identifier.citedreference | Jessen U., Novitskaya V., Pedersen N., Serup P., Berezin V. and Bock E. ( 2001 ) The transcription factors CREB and c-Fos play key roles in NCAM-mediated neuritogenesis in PC12-E2 cells. J. Neurochem. 79, 1149 – 1160. | en_US |
dc.identifier.citedreference | Kantor L. and Gnegy M. E. ( 1998a ) Enhanced AMPH-mediated DA release in AMPH-pretreated rats depends on Ca 2+ and CaM-dependent protein kinase II. FASEB J. 12, A159. | en_US |
dc.identifier.citedreference | Kantor L. and Gnegy M. E. ( 1998b ) Protein kinase C inhibitors block amphetamine-mediated dopamine release in rat striatal slices. J. Pharmacol. Exp. Ther. 284, 594 – 598. | en_US |
dc.identifier.citedreference | Kantor L., Hewlett G. H. and Gnegy M. E. ( 1999 ) Enhanced amphetamine- and K + -mediated dopamine release in rat striatum after repeated amphetamine: differential requirements for Ca 2+ - and calmodulin-dependent phosphorylation and synaptic vesicles. J. Neurosci. 19, 3801 – 3808. | en_US |
dc.identifier.citedreference | Kantor L., Hewlett G. H., Park Y. H., Richardson-Burns S. M., Mellon M. J. and Gnegy M. E. ( 2001 ) Protein kinase C and intracellular calcium are required for amphetamine-mediated dopamine release via the norepinephrine transporter in undifferentiated PC12 cells. J. Pharmacol. Exp. Ther. 297, 1016 – 1024. | en_US |
dc.identifier.citedreference | Kantor L., Park Y. H., Wang K. K. W. and Gnegy M. E. ( 2002 ) Enhanced amphetamine-mediated dopamine release develops in PC12 cells after repeated amphetamine treatment. Eur. J. Pharmacol. 451, 27 – 35. | en_US |
dc.identifier.citedreference | Koike T. ( 1983 ) Nerve growth factor-induced neurite outgrowth of rat pheochromocytoma PC 12 cells: dependence on extracellular Mg 2+ and Ca 2+. Brain Res. 289, 293 – 303. | en_US |
dc.identifier.citedreference | Kolch W., Heidecker G., Kochs G., Hummel R., Vahidi H., Mischak H., Finkenzeller G., Marme D. and Rapp U. R. ( 1993 ) Protein kinase C alpha activates RAF-1 by direct phosphorylation. Nature 364, 249 – 252. | en_US |
dc.identifier.citedreference | Kramer H. K., Poblete J. C. and Azmitia E. C. ( 1998 ) Characterization of the translocation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetamine (MDMA/ecstasy) in synaptosomes: evidence for a presynaptic localization involving the serotonin transporter (SERT). Neuropsychopharmacology 19, 265 – 277. | en_US |
dc.identifier.citedreference | Lazarovici P., Jiang H. and Fink D. Jr ( 1998 ) The 38-amino-acid form of pituitary adenylate cyclase-activating polypeptide induces neurite outgrowth in PC12 cells that is dependent on protein kinase C and extracellular signal-regulated kinase but not on protein kinase A, nerve growth factor receptor tyrosine kinase, p21 (ras) G protein, and pp60 (c-src) cytoplasmic tyrosine kinase. Mol. Pharmacol. 54, 547 – 558. | en_US |
dc.identifier.citedreference | Licata S. C. and Pierce R. C. ( 2003 ) The roles of calcium/calmodulin-dependent and Ras/mitogen-activated protein kinases in the development of psychostimulant-induced behavioral sensitization. J. Neurochem. 85, 14 – 22. | en_US |
dc.identifier.citedreference | Liu H., Palmer D., Jimmo S. L., Tilley D. G., Dunkerley H. A., Pang S. C. and Maurice D. H. ( 2000 ) Expression of phosphodiesterase 4D (PDE4D) is regulated by both the cyclic AMP-dependent protein kinase and mitogen-activated protein kinase signaling pathways. A potential mechanism allowing for the coordinated regulation of PDE4D activity and expression in cells. J. Biol. Chem. 275, 26615 – 26624. | en_US |
dc.identifier.citedreference | Molderings G. J., Bonisch H., Hammermann R., Gothert M. and Bruss M. ( 2002 ) Noradrenaline release-inhibiting receptors on PC12 cells devoid of alpha(2(–)) and CB(1) receptors: similarities to presynaptic imidazoline and edg receptors. Neurochem. Int. 40, 157 – 167. | en_US |
dc.identifier.citedreference | Mons N., Decorte L., Jaffard R. and Cooper D. M. ( 1998 ) Ca 2+ -sensitive adenylyl cyclases, key integrators of cellular signalling. Life Sci. 62, 1647 – 1652. | en_US |
dc.identifier.citedreference | Nakafuku M. and Kaziro Y. ( 1993 ) Epidermal growth factor and transforming growth factor-alpha can induce neuronal differentiation of rat pheochromocytoma PC12 cells under particular culture conditions. FEBS Lett. 315, 227 – 232. | en_US |
dc.identifier.citedreference | Narkar V. A., Hussain T., Pedemonte C. and Lokhandwala M. F. ( 2001 ) Dopamine D (2) receptor activation causes mitogenesis via p44/42 mitogen-activated protein kinase in opossum kidney cells. J. Am. Soc. Nephrol. 12, 1844 – 1852. | en_US |
dc.identifier.citedreference | Nishizuka Y. ( 1988 ) The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 334, 661 – 665. | en_US |
dc.identifier.citedreference | Oak J. N., Lavine N. and Van Tol H. H. ( 2001 ) Dopamine D(4) and D(2L) receptor stimulation of the mitogen-activated protein kinase pathway is dependent on trans-activation of the platelet-derived growth factor receptor. Mol. Pharmacol. 60, 92 – 103. | en_US |
dc.identifier.citedreference | Otani S., Auclair N., Desce J. M., Roisin M. P. and Crepel F. ( 1999 ) Dopamine receptors and groups I and II mGluRs cooperate for long-term depression induction in rat prefrontal cortex through converging postsynaptic activation of MAP kinases. J. Neurosci. 19, 9788. | en_US |
dc.identifier.citedreference | Park Y. H., Kantor L., Wang K. K. W. and Gnegy M. E. ( 2002 ) Repeated, intermittent treatment with amphetamine induces neurite outgrowth in rat pheochromocytoma cells (PC12 cells). Brain Res. 951, 43 – 52. | en_US |
dc.identifier.citedreference | Pierce R. C., Pierce-Bancroft A. F. and Prasad B. M. ( 1999 ) Neurotrophin-3 contributes to the initiation of behavioral sensitization to cocaine by activating the Ras/Mitogen-activated protein kinase signal transduction cascade. J. Neurosci. 19, 8685 – 8695. | en_US |
dc.identifier.citedreference | Ramamoorthy S., Giovanetti E., Qian Y. and Blakely R. D. ( 1998 ) Phosphorylation and regulation of antidepressant-sensitive serotonin transporters. J. Biol. Chem. 273, 2458 – 2466. | en_US |
dc.identifier.citedreference | Robinson T. E. ( 1991 ) The neurobiology of amphetamine psychosis: Evidence from studies with an animal model. In: Taniguchi Symposia on Brain Sciences, Vol. 14, Biological Basis of Schizophrenic Disorders ( Nakazawa, T., ed.), pp. 185 – 201. Japan Scientific Societies Press, Tokyo. | en_US |
dc.identifier.citedreference | Robinson T. E. and Becker J. B. ( 1986 ) Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. Rev. 11, 157 – 198. | en_US |
dc.identifier.citedreference | Robinson T. E. and Kolb B. ( 1997 ) Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine. J. Neurosci. 17, 8491 – 8497. | en_US |
dc.identifier.citedreference | Robinson T. E. and Kolb B. ( 1999 ) Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine. Eur. J. Neurosci. 11, 1598 – 1604. | en_US |
dc.identifier.citedreference | Rothman R. B., Dersch C. M., Carroll F. I. and Ananthan S. ( 2002 ) Studies of the biogenic amine transporters. VIII: identification of a novel partial inhibitor of dopamine uptake and dopamine transporter binding. Synapse 43, 268 – 274. | en_US |
dc.identifier.citedreference | Seiden L. S., Sabol K. E. and Ricaurte G. A. ( 1993 ) Amphetamine: Effects on catecholamine systems and behavior. Annu. Rev. Pharmacol. Toxicol. 33, 639 – 677. | en_US |
dc.identifier.citedreference | Self D. W., Genova L. M., Hope B. T., Barnhart W. J., Spencer J. J. and Nestler E. J. ( 1998 ) Involvement of cAMP-dependent protein kinase in the nucleus accumbens in cocaine self-administration and relapse of cocaine-seeking behavior. J. Neurosci. 18, 1848 – 1859. | en_US |
dc.identifier.citedreference | Steketee J. D. ( 1997 ) Cocaine-induced behavioral sensitization is associated with increased protein kinase C activity in the ventral tegmental area. Neurosci. Res. Commun. 20, 59 – 67. | en_US |
dc.identifier.citedreference | Stroemer R. P., Kent T. A. and Hulsebosch C. E. ( 1998 ) Enhanced neocortical neural sprouting, synaptogenesis, and behavioral recovery with d-amphetamine therapy after neocortical infarction in rats. Stroke 29, 2381 – 2393. | en_US |
dc.identifier.citedreference | Tolliver B. K., Ho L. B., Reid M. S. and Berger S. P. ( 1996 ) Evidence for involvement of ventral tegmental area cyclic AMP systems in behavioral sensitization to psychostimulants. J. Pharmacol. Exp. Ther. 278, 411 – 420. | en_US |
dc.identifier.citedreference | Tolliver B. K., Ho L. B., Fox L. M. and Berger S. P. ( 1999 ) Necessary role for ventral tegmental area adenylate cyclase and protein kinase A in induction of behavioral sensitization to intraventral tegmental area amphetamine. J. Pharmacol. Exp. Ther. 289, 38 – 47. | en_US |
dc.identifier.citedreference | Trilivas I. and Brown J. H. ( 1989 ) Increases in intracellular Ca 2+ regulate the binding of [3H]phorbol 12,13-dibutyrate to intact 1321N1 astrocytoma cells. J. Biol. Chem. 264, 3102 – 3107. | en_US |
dc.identifier.citedreference | Valjent E., Corvol J. C., Pages C., Besson M. J., Maldonado R. and Caboche J. ( 2000 ) Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties. J. Neurosci. 20, 8701 – 8709. | en_US |
dc.identifier.citedreference | Vaudry D., Stork P. J., Lazarovici P. and Eiden L. E. ( 2002 ) Signaling pathways for PC12 cell differentiation: making the right connections. Science 296, 1648 – 1649. | en_US |
dc.identifier.citedreference | Williams N. G., Zhong H. and Minneman K. P. ( 1998 ) Differential coupling of alpha1-, alpha2-, and beta-adrenergic receptors to mitogen-activated protein kinase pathways and differentiation in transfected PC12 cells. J. Biol. Chem. 273, 24624 – 24632. | en_US |
dc.identifier.citedreference | Wolf M. E. ( 1998 ) The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog. Neurobiol. 54, 679 – 720. | en_US |
dc.identifier.citedreference | Yan Z., Feng J., Fienberg A. A. and Greengard P. ( 1999 ) D2 dopamine receptors induce mitogen-activated protein kinase and cAMP response element-binding protein phosphorylation in neurons. Proc. Natl Acad. Sci. USA 96, 11607. | en_US |
dc.identifier.citedreference | Yao H., York R. D., Misra-Press A., Carr D. W. and Stork P. J. ( 1998 ) The cyclic adenosine monophosphate-dependent protein kinase (PKA) is required for the sustained activation of mitogen-activated kinases and gene expression by nerve growth factor. J. Biol. Chem. 273, 8240 – 8247. | en_US |
dc.identifier.citedreference | Yingling J. D., Fuller L. Z. and Jackson B. A. ( 1994 ) Modulation of cyclic AMP metabolism by protein kinase C in PC18 cells. Neurosci. Lett. 166, 157 – 160. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.